The company has secured a tender from Tamil Nadu Medical Services Corporation (TNMSC) for the supply of generic medicines,valued between Rs.150 million and Rs. 180 million
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has won a tender from Tamil Nadu Medical Services Corporation (TNMSC), a state government body, to supply generic medicines worth between Rs. 150 million and Rs. 180 million. The supplies, under the company's Fredun Gx brand, will begin in Q1 FY26 and run over a 14-month period. TNMSC procures essential drugs for government medical institutions across Tamil Nadu, making this a domestic public-sector order. The company manufactures a wide range of products including antihypertensives, antidiabetics, ARVs, and nutraceuticals, and primarily exports to Africa, Southeast Asia, CIS countries, and Latin America.
This is a positive development that adds a credible government-backed revenue stream over the next 14 months, though the order size suggests a modest impact on overall financials. It strengthens Fredun Pharma's presence in the public healthcare segment and could support order book visibility going into FY26.